National Medical Care Co. · TADAWUL:4005
National Medical Care — 9M 2023 Earnings Presentation
21 slides from National Medical Care's earnings presentation, Nov 6, 2023
Slide 1: Earnings Presentation 9M 2023
Earnings Presentation 9M 2023 6 November, 2023 | Riyadh, KSA
Slide 2: Performance Highlights and Strategy
Performance Highlights and Strategy Care Medical Earnings Presentation – 06/11/23 2
Slide 3: Operating and Financial Performance Highlights
Operating and Financial Performance Highlights Solid operational efficiency paired with rapidly improving financial outcomes Revenue Surgeries 18,588 476.1 Total patients in 9M 2023 9M 2023 918 9M 2023 thousand +4% year-on-year 782 SAR mn +17% year-on-year 764 14,334 +8% year-on-year 12,722 Inpatien
Slide 4: Care Growth Strategy
Care Growth Strategy Strategy stands to reshape the organization, boost Company's performance and transform patient care Strategic Objectives Extend Serve Deliver Realize A set of carefully designed Extend health Serve new Deliver Realize potential service offering population exceptional of value in
Slide 5: Care Growth Strategy: Completed Strategic Initiatives
Care Growth Strategy: Completed Strategic Initiatives Finalized initiatives boost revenue, broaden segments, and strengthen patient and partner ties Expansion Home Healthcare Services Executive Health Check Launched Home Healthcare Services to enhance client satisfaction Introduced an executive heal
Slide 6: Care Growth Strategy: Key Strategic Initiatives Underway
Care Growth Strategy: Key Strategic Initiatives Underway Ongoing initiatives prioritize further business growth, operational refinement, and stronger relationships Expansion Mergers & Acquisitions New Hospital in Riyadh Mental Health Platform / FHCC Utilize merger and acquisition Set up a cutting-ed
Slide 7: Operating and Financial Performance
Operating and Financial Performance Care Medical Earnings Presentation – 06/11/23 7
Slide 8: Operational Trends
Operational Trends Patient numbers growth driven by more referrals, offset by the completion of a significant contract Operational Highlights Inpatients Admissions Quarterly Trend SAR mn 3Q2023 3Q2022 Δ% 9M2023 9M2022 Δ% (Admissions) Inpatient admissions 5,405 5,389 +0% 15,967 15,245 +5% +0% Outpati
Slide 9: Income Statement
Income Statement Strong profitability improvement driven by robust operations, better pricing, and cost control efforts Income Statement Highlights Net Profit Development SAR mn 3Q2023 3Q2022 Δ% 9M2023 9M2022 Δ% (SAR mn) Revenues 275 238 +16% 782 666 +17% Cost of revenues (184) (156) +18% (519) (455
Slide 10: Revenue Trends
Revenue Trends Revenue in 9M 2023 fueled by increasing number of referrals from key clients and price hikes Revenue Development Revenue by Business Unit (9M 2023) (SAR mn) (SAR mn) 4 +17% Malaz branch, 45.2% 3 71 2 SAR 782mn (8) 782 1 3 (28) Rawabi branch, 54.8% 78 0 666 Revenue by Payer (9M 2023) (
Slide 11: Costs Overview
Costs Overview Total expenses growth slower than the rise in revenue, creating a favourable operating leverage effect Total Expenses Breakdown (9M 2023) Cost of Revenues Breakdown (9M 2023) +12% (SAR mn) (SAR mn) 4 62.5% Operating expenses, 12.3% Salaries & benefits 9M 2023 YoY 3 26.6% Medicines & c
Slide 12: Balance Sheet Highlights
Balance Sheet Highlights Solid balance sheet, marked by a significant cash reserve and a more efficient cash conversion cycle Balance Sheet Highlights Cash Conversion Cycle1 Trend SAR mn 3Q2023 4Q2022 Δ% 3Q2022 Δ% (Days) Total Non-Current Assets 754 657 +15% 660 +14% -48% Total Current Assets 1,157
Slide 13: Receivables Management
Receivables Management Better receivables management through the efficient clearance of GOSI's collections backlog Trade Receivables1 Development Trade Receivables1 Structure (end of 3Q 2023) (SAR mn) (SAR mn) 37.1% MoH -38% 27.3% GOSI 862 22.9% Insurance 6.5% Cash 6.1% Other 111 1 536 Trade Receiva
Slide 14: Cash Flow Highlights
Cash Flow Highlights Cash flow from operations supported by stronger results and improvement in working capital Cash Flow Highlights Cash Flow From Operations Development SAR mn 3Q2023 3Q2022 Δ% 9M2023 9M2022 Δ% (SAR mn) 436 484 Net Profit before zakat 82 50 +62% 202 137 +47% Non-cash adjustments (2
Slide 15: Q&A Session
Q&A Session Care Medical Earnings Presentation – 06/11/23 15
Slide 16: Appendix
Appendix Care Medical Earnings Presentation – 06/11/23 16
Slide 17: Operating Performance Overview (1/2)
Operating Performance Overview (1/2) Total Patients Trend Surgeries Trend (Thousand patients) (Thousand surgeries) +9% CAGR +10% CAGR 639 19 532 16 453 396 13 362 254 13 158 193 10 140 136 295 339 385 256 227 FY18 -13% FY19 -9% FY20 +47% FY21 +20% FY22 Rawabi branch Malaz branch FY18 -18% FY19 +26%
Slide 18: Operating Performance Overview (2/2)
Operating Performance Overview (2/2) Occupied Beds Trend Bed Occupancy Trend (Occupied beds) (%) -1% CAGR 82.3% 80.3% 79.2% 78.8% 77.6% 539 516 526 508 519 298 298 286 283 292 241 218 240 225 227 FY18 -4% FY19 +2% FY20 -3% FY21 +2% FY22 FY18 FY19 FY20 FY21 FY22 Rawabi branch Malaz branch Inpatient D
Slide 19: Financial Performance Overview
Financial Performance Overview Total Revenue Trend EBITDA Trend (SAR mn) (SAR mn) +5% CAGR +11% CAGR 845 918 243 764 809 214 708 174 179 159 FY18 -7% FY19 +14% FY20 +5% FY21 +9% FY22 FY18 +9% FY19 +3% FY20 +19% FY21 +13% FY22 Net Profit Trend Margins Trend (SAR mn) (%) +29% CAGR 31.6% 170 26.5% 21.8
Slide 20: Contacts
Contacts Institutional investor contact Care Investor Relations Care.IR@care.med.sa +966-11-493-1881 ext. 123 & 135 Care Medical Earnings Presentation – 06/11/23 20
Slide 21: Disclaimer
Disclaimer All information included in this document is for general use only and has not been independently verified, nor does it constitute or form part of any invitation or inducement to engage in any investment activity, nor does it constitute an offer or invitation or recommendation to buy or su
National Medical Care Company (Care) — 9M 2023 Earnings Presentation on 6ix